Robert Dee Etherington - 16 Sep 2026 Form 4 Insider Report for Clene Inc. (CLNN)

Reporting relationship: President & CEO, Director
Issuer ticker: CLNN
Reported as of: 16 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Sep 2026, 13:41:42 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jerome T. Miraglia POA

Key filing fact

Robert Dee Etherington filed Form 4 for Clene Inc. (CLNN) on 18 Sep 2026.

Key facts

This page summarizes Robert Dee Etherington's Form 4 filing for Clene Inc. (CLNN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Sep 2026, 13:41.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001835330 Primary reporting owner

Etherington Robert Dee

Relationship: President & CEO, Director
Address: 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Signature: /s/ Jerome T. Miraglia POA
Signature date: 18 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLNN transaction

common stock

Award

Transaction value
Shares: +15,244
Change %: +38%
Price: $3.28^*
Shares after: 55,393
Date: 16 Sep 2026
Ownership: Direct
Footnotes: F1

CLNN holding

common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 636
Date: 16 Sep 2026
Ownership: By LLC
Footnotes: F2

CLNN holding

common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,250
Date: 16 Sep 2026
Ownership: By trust
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Mr. Etherington purchased 15,244 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended.

Footnote F2

The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may be deemed to be beneficially owned by Mr. Etherington.

Footnote F3

The securities are owned by the Etherington Revocable Trust. Mr. Etherington is the co-trustee of the Etherington Revocable Trust. The shares owned by the Etherington Revocable Trust may be deemed to be owned by Mr. Etherington.